These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 23990684

  • 1. 99mTc-sestamibi scintigraphy to monitor the long-term efficacy of enzyme replacement therapy on bone marrow infiltration in patients with Gaucher disease.
    Erba PA, Minichilli F, Giona F, Linari S, Dambrosia J, Pierini A, Filocamo M, Di Rocco M, Buffoni F, Brady RO, Mariani G.
    J Nucl Med; 2013 Oct; 54(10):1717-24. PubMed ID: 23990684
    [Abstract] [Full Text] [Related]

  • 2. Severity of bone marrow involvement in patients with Gaucher's disease evaluated by scintigraphy with 99mTc-sestamibi.
    Mariani G, Filocamo M, Giona F, Villa G, Amendola A, Erba P, Buffoni F, Copello F, Pierini A, Minichilli F, Gatti R, Brady RO.
    J Nucl Med; 2003 Aug; 44(8):1253-62. PubMed ID: 12902415
    [Abstract] [Full Text] [Related]

  • 3. Tc-99m sestamibi bone marrow scintigraphy in Gaucher disease.
    Aharoni D, Krausz Y, Elstein D, Hadas-Halpern I, Zimran A.
    Clin Nucl Med; 2002 Jul; 27(7):503-9. PubMed ID: 12072778
    [Abstract] [Full Text] [Related]

  • 4. Standardization of MRI and Scintigraphic Scores for Assessing the Severity of Bone Marrow Involvement in Adult Patients With Type 1 Gaucher Disease.
    Mariani G, Perri M, Minichilli F, Ortori S, Linari S, Giona F, Di Rocco M, Cappellini MD, Guidoccio F, Erba PA.
    AJR Am J Roentgenol; 2016 Jun; 206(6):1245-52. PubMed ID: 27057587
    [Abstract] [Full Text] [Related]

  • 5. Scintigraphic findings on 99mTc-MDP, 99mTc-sestamibi and 99mTc-HMPAO images in Gaucher's disease.
    Mariani G, Molea N, La Civita L, Porciello G, Lazzeri E, Ferri C.
    Eur J Nucl Med; 1996 Apr; 23(4):466-70. PubMed ID: 8612670
    [Abstract] [Full Text] [Related]

  • 6. Technetium-99m-sestamibi scintigraphy in multiple myeloma and related gammopathies: a useful tool for the identification and follow-up of myeloma bone disease.
    Balleari E, Villa G, Garrè S, Ghirlanda P, Agnese G, Carletto M, Clavio M, Ferrando F, Gobbi M, Mariani G, Ghio R.
    Haematologica; 2001 Jan; 86(1):78-84. PubMed ID: 11146575
    [Abstract] [Full Text] [Related]

  • 7. [Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI].
    Tóth J, Szücs FZ, Benkö K, Maródi L.
    Orv Hetil; 2003 Apr 20; 144(16):749-55. PubMed ID: 12778625
    [Abstract] [Full Text] [Related]

  • 8. Scintigraphic monitoring of reticuloendothelial system in patients with type 1 Gaucher disease on enzyme replacement therapy.
    Lorberboym M, Pastores GM, Kim CK, Hermann G, Glajchen N, Machac J.
    J Nucl Med; 1997 Jun 20; 38(6):890-5. PubMed ID: 9189137
    [Abstract] [Full Text] [Related]

  • 9. Bone marrow involvement in Gaucher disease at MRI : what long-term evolution can we expect under enzyme replacement therapy?
    Fedida B, Touraine S, Stirnemann J, Belmatoug N, Laredo JD, Petrover D.
    Eur Radiol; 2015 Oct 20; 25(10):2969-75. PubMed ID: 25875285
    [Abstract] [Full Text] [Related]

  • 10. Is there a role for scintigraphic imaging of bone manifestations in Gaucher disease? A review of the literature.
    Mikosch P, Kohlfürst S, Gallowitsch HJ, Kresnik E, Lind P, Mehta AB, Hughes DA.
    Nuklearmedizin; 2008 Oct 20; 47(6):239-47. PubMed ID: 19057797
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of Bone Marrow Infiltration in Non-Neuropathic Gaucher Disease Patients with Use of Whole-Body MRI--A Retrospective Data Analysis.
    Laudemann K, Moos L, Mengel KE, Lollert A, Reinke J, Brixius-Huth M, Wagner D, Düber C, Staatz G.
    Rofo; 2015 Dec 20; 187(12):1093-8. PubMed ID: 26200566
    [Abstract] [Full Text] [Related]

  • 12. Gaucher disease status and treatment assessment: pilot study using magnetic resonance spectroscopy bone marrow fat fractions in pediatric patients.
    Degnan AJ, Ho-Fung VM, Wang DJ, Ficicioglu C, Jaramillo D.
    Clin Imaging; 2020 Jul 20; 63():1-6. PubMed ID: 32120306
    [Abstract] [Full Text] [Related]

  • 13. Effect of enzyme replacement therapy with imiglucerase on BMD in type 1 Gaucher disease.
    Wenstrup RJ, Kacena KA, Kaplan P, Pastores GM, Prakash-Cheng A, Zimran A, Hangartner TN.
    J Bone Miner Res; 2007 Jan 20; 22(1):119-26. PubMed ID: 17032149
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [A retrospective study on enzyme replacement therapy in patients with Gaucher disease].
    Duan YL, Zhang YH, Zang Y, Shi HP, Zhang WM, Hu YM.
    Zhonghua Er Ke Za Zhi; 2006 Sep 20; 44(9):653-6. PubMed ID: 17217655
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of treatment response to enzyme replacement therapy with Velaglucerase alfa in patients with Gaucher disease using whole-body magnetic resonance imaging.
    Laudemann K, Moos L, Mengel E, Lollert A, Hoffmann C, Brixius-Huth M, Wagner D, Düber C, Staatz G.
    Blood Cells Mol Dis; 2016 Mar 20; 57():35-41. PubMed ID: 26852653
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bone manifestations in neuronopathic Gaucher disease while receiving high-dose enzyme replacement therapy.
    Potnis KC, Flueckinger LB, Ha CI, Upadia J, Frush DP, Kishnani PS.
    Mol Genet Metab; 2019 Feb 20; 126(2):157-161. PubMed ID: 30448006
    [Abstract] [Full Text] [Related]

  • 20. Magnetic resonance imaging of bone marrow changes in Gaucher disease during enzyme replacement therapy: first German long-term results.
    Poll LW, Koch JA, vom Dahl S, Willers R, Scherer A, Boerner D, Niederau C, Häussinger D, Mödder U.
    Skeletal Radiol; 2001 Sep 20; 30(9):496-503. PubMed ID: 11587517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.